Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
International Journal of Molecular Sciences
|
August 8, 2018
The Winding Roadmap of Biomarkers toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer
Carlotta Antoniotti, Elena Ongaro, Alfredo Falcone, et al.
Oncoimmunology
|
August 9, 2023
Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response
Assia Hijazi, Carlotta Antoniotti, Chiara Cremolini, et al.
Nature Reviews. Clinical Oncology
|
November 18, 2024
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
Paolo Ciracì, Vittorio Studiale, Ada Taravella, et al.
Cancer Treatment Reviews
|
December 11, 2020
Treatments after first progression in metastatic colorectal cancer. A literature review and evidence-based algorithm
Carlotta Antoniotti, Roberto Moretto, Daniele Rossini, et al.
Cancers
|
October 27, 2022
Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability
Beatrice Borelli, Carlotta Antoniotti, Martina Carullo, et al.
Cancer Treatment Reviews
|
April 7, 2026
Comprehensive genomic profiling in solid tumours: Navigating promise, challenges, and pathways to clinical integration
Vittorio Studiale, Ada Taravella, Matteo Landi, et al.
Nature Reviews. Clinical Oncology
|
July 29, 2015
First-line chemotherapy for mCRC—a review and evidence-based algorithm
Chiara Cremolini, Marta Schirripa, Carlotta Antoniotti, et al.
Expert Review of Anticancer Therapy
|
October 29, 2015
TAS-102 for the treatment of metastatic colorectal cancer
Lisa Salvatore, Daniele Rossini, Roberto Moretto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 13, 2023
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials
Daniele Rossini, Alessandra Boccaccino, Martina Carullo, et al.
Critical Reviews in Oncology/Hematology
|
June 20, 2015
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis
Filippo Pietrantonio, Chiara Cremolini, Fausto Petrelli, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
International Journal of Molecular Sciences
|
August 8, 2018
The Winding Roadmap of Biomarkers toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer
Carlotta Antoniotti, Elena Ongaro, Alfredo Falcone, et al.
Oncoimmunology
|
August 9, 2023
Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response
Assia Hijazi, Carlotta Antoniotti, Chiara Cremolini, et al.
Nature Reviews. Clinical Oncology
|
November 18, 2024
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
Paolo Ciracì, Vittorio Studiale, Ada Taravella, et al.
Cancer Treatment Reviews
|
December 11, 2020
Treatments after first progression in metastatic colorectal cancer. A literature review and evidence-based algorithm
Carlotta Antoniotti, Roberto Moretto, Daniele Rossini, et al.
Cancers
|
October 27, 2022
Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability
Beatrice Borelli, Carlotta Antoniotti, Martina Carullo, et al.
Cancer Treatment Reviews
|
April 7, 2026
Comprehensive genomic profiling in solid tumours: Navigating promise, challenges, and pathways to clinical integration
Vittorio Studiale, Ada Taravella, Matteo Landi, et al.
Nature Reviews. Clinical Oncology
|
July 29, 2015
First-line chemotherapy for mCRC—a review and evidence-based algorithm
Chiara Cremolini, Marta Schirripa, Carlotta Antoniotti, et al.
Expert Review of Anticancer Therapy
|
October 29, 2015
TAS-102 for the treatment of metastatic colorectal cancer
Lisa Salvatore, Daniele Rossini, Roberto Moretto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 13, 2023
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials
Daniele Rossini, Alessandra Boccaccino, Martina Carullo, et al.
Critical Reviews in Oncology/Hematology
|
June 20, 2015
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis
Filippo Pietrantonio, Chiara Cremolini, Fausto Petrelli, et al.
Page
of 9